Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
r&d
Mobilicom Wins $390,000 R&D Innovation Program to Develop Advanced Anti-Jamming Technology for Drones and Robotics
12 mars 2025 07h00 HE
|
Mobilicom Limited
Program aims to deliver breakthrough solution to address critical technology needs to combat severe wideband jamming scenarios Once developed, the new technology would be integrated into Mobilicom’s...
Bitdeer Completes Testing of its Latest SEAL03 Bitcoin Mining Chip
09 mars 2025 21h36 HE
|
SEALMINER
SINGAPORE, March 10, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for blockchain and high performance...
Ontex breidt uit in Segovia (ES) met een nieuw R&D-centrum en verhoogde productiecapaciteit
05 mars 2025 09h00 HE
|
Ontex
Officiële opening van het R&D-centrum in Segovia, gericht op innovatie in vrouwelijke zorg.Uitbreiding van de productiefaciliteit in Segovia, inclusief nieuwe productielijnen, het creëren van...
Ontex expands in Segovia (ES) with new R&D center and increased manufacturing capabilities
05 mars 2025 09h00 HE
|
Ontex
Highlights Official inauguration of the Segovia R&D center, focused on feminine care innovation.Expansion of the Segovia manufacturing site, including new production lines, job creation and...
Xeriant’s Nanotechnology is a Key Differentiator for NEXBOARD™
25 févr. 2025 08h05 HE
|
Xeriant, Inc.
Xeriant (OTCQB: XERI) enhances NEXBOARD™’s mechanical and thermal properties through the incorporation of nanotechnology
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
08 nov. 2024 15h36 HE
|
Tevogen Bio Inc
WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
29 oct. 2024 12h43 HE
|
Tevogen Bio Inc
CD8 Technology Services, LLC (“CD8 Technology”) to provide turn-key facility for Tevogen BioReinforces Tevogen Bio’s commitment to preserving shareholder valueExpected to further enhance Tevogen Bio’s...
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
28 oct. 2024 05h51 HE
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has...
Capgemini lance un ensemble de services ‘d’ingénierie augmentée’ enrichis par l’IA générative
24 oct. 2024 11h45 HE
|
Capgemini SE
Relations media :Florence Lièvre Tel.: +33 1 47 54 50 71 Email: florence.lievre@capgemini.com Capgemini lance un ensemble de services ‘d’ingénierie augmentée’ enrichis par l’IA générative Le Groupe...
Capgemini announces ‘augmented engineering’ offerings powered by Gen AI
24 oct. 2024 11h45 HE
|
Capgemini SE
Media relations:Florence LièvreTel.: +33 1 47 54 50 71Email: florence.lievre@capgemini.com Capgemini announces ‘augmented engineering’ offerings powered by Gen AI The Group is extending its...